Back to results
CompletedPhase 2

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

NCT01137526

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Site Reference ID/Investigator# 36304

Kazan', Russia

+29 additional locations

View on ClinicalTrials.gov